Mikhail Blagosklonny Education and Work History

Mikhail Blagosklonny attended the First Pavlov state Medical University of St. Petersburg. It is the place where he attained both his M.D and Ph.D. in experimental medicine and cardiology. Blagosklonny has since then been practicing medicine in various areas with a specification in cancer and aging. It has given him the expertise in the field too.

Blagosklonny was hired as an associate professor of Medicine at the New York Medical College in 2002.He was also a senior scientist at the Ordway Research Institute. He only served there till 2009 where he found a gateway to the Roswell Park Cancer Institute where he became the professor of oncology. Visit ResearchGate to keep up to date with Mikhail’s latest work.

During his studies, Mikhail Blagosklonny was keen in the search for the particular cancer therapies that help and protects healthy cells from damage by radioactive rays and chemotherapy. He also enrolled in studies that show the aging mechanism and the anti-aging treatment too. Other researchers that he was interested in are the molecular and cellular clinical and biology investigations. His research includes cellular senescence, cell cycle, signal transduction and anti- cancer therapeutics.

Mikhail Blagosklonny’s passion for aging and cancer study drove him to postulated theory of the likely role of TOR in aging and disease. Therefore, proposed that a cancer drug called rapamycin can be used as the treatment for a person’s life extension. Among other things, Mikhail has been doing editorial work for several journals as the chief author.

Some of the journals include aging, oncotarget and cell cycle. Also at the biology and cancer therapy, Mikhail serves as a junior editor. Also, Blagosklonny has written over 170 journals and research articles. Among all those journals he has also been the founding and chief editor for several others. At Roswell Park Cancer Institute, Mikhail extensive knowledge and information about cancer and aging is very significant.

It is because the institution deals on sharing possible approaches and ideas on how to curb the disease. Some of the institutional plans include how slowing down aging can prevent cancer and tissue- specific therapy cancer. Therefore, with Blagosklonny impact in the institute, it will be easy for them to come up with a solution faster than they would have anticipated. Follow Mikhail on Google Scholar

Lung Institute And Stem Cell Therapy Provide Hope For Many.

Lung disease is something that people are fighting every day. Just like other forms of disease, it does not discriminate. Lucky for everyone there are wonderful people at the Lung Institute who are working day and night in the field of regenerative medicine. One of the ways they are helping is with stem cell therapies. If you don’t already know about Lung Institute, they are a group of innovative leaders in the field of stem cell and regenerative medicine for lung disease. Lives are being improved and people are able to breathe easier because of their undying dedication to lungs and the diseases that plague them.

The Lung Institute has some of the finest doctors, reveals the Baylor College of Medicine. They all come with extensive backgrounds and are true innovative leaders. They understand how stem cells work and how to use the research to treat lung disease. In case you are new to stem cells, they are like the blocks that build life. Every organism in the human body needs them, they are essential. Because these cells are self renewing, they help to make up any type of tissue. The means that stem cells help areas to restore and rejuvenate, as a result, sick cells and replaced by new, healthy cells.

Often things like COPD, types of bronchitis, pulmonary fibrosis and emphysema can be treated with stem cells. It is not unusual to use stem cells from the patient’s own body as treatment.The basic process is simple to understand. The doctors and their staff harvest the cells from bone marrow or blood from the patient. Next those cells go through a separation process and are returned to the patient in a concentrated form. When the stem cells are introduced into the body they go through the heart’s right side and get caught in what is often called the pulmonary trap. The stem cells stay here and slow down the progression.

If you or someone you know wants more information about the process of stem cells or treatments options you should research the information on the Lung Institute website which can be found with ease by clicking here: https://lunginstitute.com

For more info, subscribe to the Lung Institute’s YouTube channel.

Follow the Lung Institute: https://twitter.com/lunginstitute?lang=en